Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Ketamine Injection in Orthognathic Surgery
NCT07066306Active, not recruiting
- Sponsor
- Bezmialem Vakif University
- Start
- Jun 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ketamine in postoperative pain, edema and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Bezmialem Vakif University. Primary endpoints: Rescue Analgesia Dose at 2 days, Postoperative Edema Calculation at 7 days and 1 more. Started Jun 2025; status: active, not recruiting.
02
Drugs
ketamine
03
Conditions
postoperative painedemapostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT07066306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07066306.